Position in HROW
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,693,703
+$538,586 QoQ
Shares Held
39,880
+21.7% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#60
of 221 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BLAIR WILLIAM & CO/IL holds $57,494,050 across 15 Drug Manufacturers - Specialty & Generic names. HROW ranks #3 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
583,869 | $41,956,826 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
51,511 | $8,681,663 | |
| 3 | HROW |
Harrow, Inc.
This page
|
39,880 | $1,693,703 | |
| 4 | ETON |
Eton Pharmaceuticals, Inc.
|
32,419 | $1,173,567 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
26,635 | $902,393 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,565 | $847,963 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
20,247 | $701,963 | |
| 8 | HLN |
Haleon plc
|
48,903 | $456,264 |
All Filings in HROW
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,693,703 | 39,880 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,155,117 | 32,760 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,342,747 | 27,403 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||